PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

PROCEPT BioRobotics Corporation

Truist Financial analyst Richard Newitter maintained a Hold rating on PROCEPT BioRobotics yesterday and set a price target of $25.00. According to ...

Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)

Analysts are intrested in these 5 stocks: ( ($PRCT) ) and ( ($FSUMF) ). Here is a breakdown of their recent ratings and the rationale behind them. ...

PROCEPT, Fortescue Trending as Analysts Turn Cautious

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PROCEPT BioRobotics (PRCT) and Guardant Health (GH) ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRCT	$19.31	-9.00%	1.89M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PRCT	$19.31	-9.0%	1.89M
3
4
5
6

PRCT

PRCT

Get PROCEPT BioRobotics Corporation Data in Excel

Get PROCEPT BioRobotics Corporation Data in Excel